Condition: Sepsis · Septic Shock · Hemodynamic Instability · Sponsor: University Hospital, Brest
In ICU, fluid challenge represents one of the cornerstones of hemodynamic care. However, fluid overload due to an excessive and/or inappropriate fluid administration could be associated with morbidity or mortality. Unfortunately, there is currently no continuous non-invasive devices to monitor fluid content at bedside. Bio reactance is a non-invasive, rapid and continuous technology developed in order to measure body fluid compartment. Monitoring devices functioning with such technology are promising to evaluate fluid overload in ICU.
This description comes directly from the study's public registry record.
Xavier Chapalain, MD · +33230337893 · xavier.chapalain@chu-brest.fr
Dauphou Eddi · dauphou.eddi@chu-brest.fr
Always discuss trial participation with your own doctor first.
| Chu Brest | Brest, France | Recruiting |
| Hegp - Aphp | Paris, France | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06572995